C Wagener

Author PubWeight™ 90.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000 3.57
2 Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 1997 2.88
3 Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. Genes Dev 2000 2.58
4 Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res 1999 2.25
5 E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 1998 2.12
6 Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J Clin Invest 1996 2.00
7 Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994 1.78
8 E2F family members are differentially regulated by reversible acetylation. J Biol Chem 2000 1.77
9 Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc Natl Acad Sci U S A 1993 1.64
10 CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell 2000 1.63
11 CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal human tissues. J Histochem Cytochem 1996 1.59
12 Methods for detection of point mutations: performance and quality assessment. IFCC Scientific Division, Committee on Molecular Biology Techniques. Clin Chem 1997 1.46
13 Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br J Cancer 1998 1.42
14 Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 1994 1.39
15 Molecular cloning of a cDNA coding biliary glycoprotein I: primary structure of a glycoprotein immunologically crossreactive with carcinoembryonic antigen. Proc Natl Acad Sci U S A 1988 1.32
16 Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 1995 1.31
17 Binding of Escherichia coli and Salmonella strains to members of the carcinoembryonic antigen family: differential binding inhibition by aromatic alpha-glycosides of mannose. Infect Immun 1991 1.28
18 Association of pp60c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas. Oncogene 1995 1.28
19 Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 1999 1.24
20 Expression of CD66a (human C-CAM) and other members of the carcinoembryonic antigen gene family of adhesion molecules in human colorectal adenomas. Cancer Res 1997 1.15
21 Monoclonal antibodies for carcinoembryonic antigen (CEA) as a model system: identification of two novel CEA-related antigens in meconium and colorectal carcinoma tissue by Western blots and differential immunoaffinity chromatography. J Immunol 1985 1.12
22 Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland. J Histochem Cytochem 1997 1.11
23 Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics. International Federation of Clinical Chemistry Scientific Division Committee on Molecular Biology Techniques. Clin Chem 1998 1.11
24 Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene 1995 1.09
25 Expression of biliary glycoprotein (CD66a) in normal and malignant breast epithelial cells. Anticancer Res 1998 1.07
26 Identification of the specific oligosaccharide sites recognized by type 1 fimbriae from Escherichia coli on nonspecific cross-reacting antigen, a CD66 cluster granulocyte glycoprotein. J Biol Chem 1993 1.06
27 Reversal of RT-PCR inhibition observed in heparinized clinical specimens. Biotechniques 1997 1.04
28 Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay. J Immunol 1983 1.04
29 CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases. Oncogene 2006 1.01
30 Escherichia coli of human origin binds to carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA). FEBS Lett 1990 0.99
31 Binding of nonspecific cross-reacting antigen, a granulocyte membrane glycoprotein, to Escherichia coli expressing type 1 fimbriae. Infect Immun 1991 0.98
32 Monoclonal, anti-domain and anti-peptide antibodies assign the molecular weight 160,000 granulocyte membrane antigen of the CD66 cluster to a mRNA species encoded by the biliary glycoprotein gene, a member of the carcinoembryonic antigen gene family. J Immunol 1993 0.97
33 CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. Oncogene 2011 0.96
34 Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer. Am J Pathol 1998 0.95
35 cis Interaction of the cell adhesion molecule CEACAM1 with integrin beta(3). Am J Pathol 2001 0.95
36 Purification and N-terminal amino acid sequence of a chondroitin sulphate/dermatan sulphate proteoglycan isolated from intima/media preparations of human aorta. Biochem J 1991 0.95
37 Identification of membrane antigens in granulocytes and colonic carcinoma cells by a monoclonal antibody specific for biliary glycoprotein, a member of the carcinoembryonic antigen family. Cancer Lett 1991 0.95
38 Localization and concentration of carcinoembryonic antigen (CEA) in gastrointestinal tumors: correlation with CEA levels in plasma. J Natl Cancer Inst 1981 0.94
39 Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies. J Immunol 1983 0.94
40 Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer 1996 0.93
41 Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction. Eur J Clin Chem Clin Biochem 1997 0.93
42 Atypical squamous cells of undetermined significance: audit and the impact of potential litigation. Retrospective review of 682 cases. Cytopathology 2003 0.91
43 Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen. Cancer Res 1992 0.91
44 Delineation of four carcinoembryonic antigen (CEA) related antigens in normal plasma by transblot studies using monoclonal anti-CEA antibodies with different epitope specificities. Mol Immunol 1985 0.90
45 Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice. J Exp Med 1996 0.89
46 Activation of the phosphatidylinositol cycle in spreading cells. Exp Cell Res 1989 0.87
47 Cell- and region-specific expression of biliary glycoprotein and its messenger RNA in normal human colonic mucosa. Cancer Res 1995 0.87
48 Use of biotin-labeled monoclonal antibodies and avidin-peroxidase conjugates for the determination of epitope specificities in a solid-phase competitive enzyme immunoassay. J Immunol Methods 1984 0.86
49 CEA-Related CAMs. Handb Exp Pharmacol 2004 0.86
50 Dysregulation of carcinoembryonic antigen group members CGM2, CD66a (biliary glycoprotein), and nonspecific cross-reacting antigen in colorectal carcinomas. Comparative analysis by northern blot and in situ hybridization. Am J Pathol 1997 0.85
51 Sensitive and specific cytokeratin 18 reverse transcription-polymerase chain reaction that excludes amplification of processed pseudogenes from contaminating genomic DNA. Clin Chem 1997 0.85
52 Cervical cancer screening in Luxembourg. Eur J Cancer 2000 0.85
53 The adhesion molecule CEACAM1 (CD66a, C-CAM, BGP) is specifically expressed by the extravillous intermediate trophoblast. Am J Pathol 2000 0.85
54 The putative role of members of the CEA-gene family (CEA, NCA an BGP) as ligands for the bacterial colonization of different human epithelial tissues. Zentralbl Bakteriol 1991 0.85
55 Biochemical and immunochemical aspects of carcinoembryonic antigen (CEA) and CEA related antigens: current status and future perspectives. J Clin Chem Clin Biochem 1982 0.84
56 External quality assessment of molecular biology-based methods used in laboratories of clinical chemistry and human genetics. Clin Chem Lab Med 1998 0.84
57 Glycoproteins of the carcinoembryonic antigen (CEA) family are expressed in sweat and sebaceous glands of human fetal and adult skin. J Invest Dermatol 1996 0.83
58 Cell adhesion molecule CEACAM1 associates with paxillin in granulocytes and epithelial and endothelial cells. Exp Cell Res 2000 0.83
59 Expression of a glycoprotein of the carcinoembryonic antigen family in normal and neoplastic sebaceous glands. Limited role of carcinoembryonic antigen as a sweat gland marker. J Am Acad Dermatol 1996 0.82
60 Guided tissue regeneration in interproximal defects in the monkey. Int J Periodontics Restorative Dent 1992 0.82
61 [Second International Expert Meeting of the German Foundation for Cancer Research, "Current trends in cancer research." Critical review of tumour markers in diagnosis and surveillance]. Onkologie 1980 0.81
62 Transblot studies with biotin-labeled proteins: electrophoretic mobilities and detection limits. Anal Biochem 1986 0.81
63 Tumour diagnosis by PCR-based detection of tumour cells. Scand J Clin Lab Invest Suppl 1995 0.81
64 Characterization of biotin-labeled proteoglycans by electrophoretic separation on minigels and blotting onto nylon membranes prior and after enzymatic digestion. Anal Biochem 1989 0.81
65 Solution-phase RIA and solid-phase EIA using avidin-biotin systems for analysis of monoclonal antibody epitopes and affinity constants. Methods Enzymol 1986 0.80
66 Immunohistochemical demonstration of carcinoembryonic antigen in normal, transitional and inflamed colonic mucosa. Oncodev Biol Med 1981 0.80
67 A highly sensitive method for the demonstration of carcinoembryonic antigen in normal and neoplastic colonic tissue. Histochemistry 1978 0.80
68 The microbial receptor CEACAM3 is linked to the calprotectin complex in granulocytes. Biochem Biophys Res Commun 2001 0.79
69 Induction of Bax-alpha precedes apoptosis in a human B lymphoma cell line: potential role of the bcl-2 gene family in surface IgM-mediated apoptosis. Eur J Immunol 1995 0.79
70 Diagnostic sensitivity, diagnostic specificity and predictive value of the determination of tumour markers. J Clin Chem Clin Biochem 1984 0.79
71 Enrichment of mutant KRAS alleles in pancreatic juice by subtractive iterative polymerase chain reaction. Lab Invest 2001 0.78
72 Carcinoembryonic antigen (CEA) and two crossreacting antigens of 165 kD and 105 kD isolated from meconium exhibit identical amino terminal sequences. Biochem Biophys Res Commun 1987 0.78
73 Isolation of DNA from stool and bodily fluids for PCR amplification. Biotechniques 1996 0.78
74 Comparative studies on the radioimmunological determination of carcinoembryonic antigen in tumour tissue. J Clin Chem Clin Biochem 1978 0.77
75 Methods for detection of point mutations: performance and quality assessment. The IFCC Scientific Division, Committee on Molecular Biology Techniques. J Int Fed Clin Chem 1997 0.77
76 A monoclonal anti-idiotypic antibody bearing the image of an epitope specific to the human carcinoembryonic antigen. Int J Cancer 1992 0.76
77 CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation. J Pathol 2007 0.76
78 Binding inhibition of type 1 fimbriae to human granulocytes: a flow cytometric inhibition assay using trivalent cluster mannosides. Med Microbiol Immunol 2001 0.76
79 Enrichment of mutant alleles by chromatographic removal of wild type alleles: a new principle for the detection of alleles with unknown point mutations at excess of wild type alleles. Clin Chem Lab Med 1999 0.76
80 Molecular characterization of a cloned idiotypic cascade containing a network antigenic determinant specific for the human carcinoembryonic antigen. J Biol Chem 1993 0.76
81 Immunohistochemical localisation of alpha-fetoprotein (AFP) in germ cell tumours: evidence for AFP production by tissues different from endodermal sinus tumour. Oncology 1981 0.76
82 In vitro influence of Mycoplasma species on the stimulation of human polymorphonuclear granulocytes. Zentralbl Bakteriol Mikrobiol Hyg A 1988 0.75
83 Consequences of a National Mammography Screening Program on diagnostic procedures and tumor sizes in breast cancer. A retrospective study of 1540 cases diagnosed and histologically confirmed between 1995 and 1997. Pathol Res Pract 2001 0.75
84 Sensitivity of assays designed for the detection of disseminated epithelial tumor cells is influenced by cell separation methods. Clin Chem 2000 0.75
85 Expression pattern of the adhesion molecule CEACAM1 (C-CAM, CD66a, BGP) in gestational trophoblastic lesions. Int J Gynecol Pathol 2001 0.75
86 Rapid expression of c-fos specific messenger RNA after wounding of a BALB/c-3T3 fibroblast monolayer. J Clin Chem Clin Biochem 1987 0.75
87 [How reliable is the determination of the carcinoembryonic antigen?]. Dtsch Med Wochenschr 1983 0.75
88 Structure and genetic engineering of antigens and antibodies: applications in immunoassays. Ann Biol Clin (Paris) 1992 0.75
89 Determination of epitope specificities and affinities of monoclonal antibodies in solution phase using biotin-labeled carcinoembryonic antigen and avidin as precipitating agent. J Immunol Methods 1989 0.75
90 Structure and genetic engineering of antigens and antibodies. Applications in immunoassays. J Int Fed Clin Chem 1993 0.75
91 Award of the Sarstedt Research Prize 1997. Eur J Clin Chem Clin Biochem 1997 0.75
92 Rapid screening for Tp53 mutations by temperature gradient gel electrophoresis: a comparison with SSCP analysis. Hum Mol Genet 1993 0.75
93 High background levels compromise the use of cardiac troponin I RNA detection in peripheral blood as a diagnostic tool in cardiology. Int J Clin Lab Res 2000 0.75
94 Distinction of highly homologous pregnancy-specific glycoprotein (PSG) isoforms by differential absorption of antisera with recombinant PSG fusion protein domains. J Immunol Methods 1994 0.75
95 [Diagnostic significance of tumour markers in clinical chemistry. Report on the workshop conference of the German society for Clinical Chemistry, held on November 15--17, 1979 in Schloss Auel (author's transl)]. J Clin Chem Clin Biochem 1980 0.75
96 Binding of carcinoembryonic antigen (CEA) to an anti-CEA immunosorbent in the presence of detergents. J Clin Chem Clin Biochem 1982 0.75
97 Factors affecting the radioimmunological determination of carcinoembryonic antigen in human plasma. J Clin Chem Clin Biochem 1978 0.75
98 Structure and genetic engineering of antigens and antibodies: applications in immunoassays. Clin Chim Acta 1992 0.75
99 Selective precipitation of biotin-labeled antigens or monoclonal antibodies by avidin for determining epitope specificities and affinities in solution-phase assays. Methods Enzymol 1990 0.75
100 [Demonstration of hepatocellular alpha 1-antitrypsin-containing inclusions in paraffin material using the immunoperoxidase technic]. Verh Dtsch Ges Pathol 1978 0.75
101 [Changes in the clinical features of pulmonary tuberculosis during the past 20 years (author's transl)]. Prax Pneumol 1975 0.75
102 Localisation of carcinoembryonic antigen in embryonic and fetal human tissues. Histochemistry 1983 0.75
103 Characterization of a variant of carcinoembryonic antigen (CEA) using monoclonal and polyclonal anti-CEA antibodies. Biochem Biophys Res Commun 1982 0.75
104 Cervical screening in Luxembourg: 1990-1999. Cytopathology 2003 0.75
105 Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues. Int J Cancer 1984 0.75
106 Neoplasms with sweat gland differentiation express various glycoproteins of the carcinoembryonic antigen (CEA) family. J Cutan Pathol 1996 0.75
107 Bitter sweetness of complexity. Top Curr Chem 2009 0.75
108 [The Tumor Immunology Study Group: tumor immunology of the gastrointestinal tract--experimental and clinical experiences]. Z Gastroenterol Verh 1988 0.75
109 Diagnostic significance and clinical application of tumour-associated antigens in man with special reference to the carcinoembryonic antigen. J Clin Chem Clin Biochem 1977 0.75
110 Quantification of carcinoembryonic antigen in serum and analysis of epitope specificities of monoclonal antibodies. Methods Enzymol 1990 0.75